MDMA is getting ever closer to becoming a legal medicine.
The federal Food and Drug Administration (FDA) is now expediting review of an application which, if approved, would allow doctors to prescribe the psychedelic for people experiencing post-traumatic stress disorder (PTSD).
Read more
Keep reading for an interview with regulatory attorney Kimberly I. Chew.
Read more
The criminalization of drug production and consumption is driving widespread environmental damage and impeding efforts to stop climate change, a new report from The International Coalition on Drug Policy Reform & Environmental Justice warned today, in advance of the International Drug Policy Reform Conference and less than two months before the UN Climate Change Conference in Dubai.
The report unveils how prohibitive drug policies – which drive drug cultivation into remote and incredibly fragile ecosystems to evade law enforcement detection – are undermining environmental progress and governance in the world’s tropical forest frontiers.
Read more
Massachusetts may be the next state to legalize psychedelic use through a voter initiative.
The newly formed Massachusetts for Mental Health Options (MMHO) committee submitted initial documents to the state Office of Campaign and Political Finance (OCPF), signaling their intent to secure ballot placement for the measure, details of which are currently sparse.
Read more
Psychedelics have been illegal in much of the world for over half a century. However, that is starting to change. As the medical and spiritual benefits of psychedelics become increasingly apparent, more cities, states, and countries are changing the laws that govern these compounds.
The following is an outline of the global laws governing psychedelics as of June 1, 2023. Fortunately, laws are constantly changing! To stay up to date on where psychedelics are legalized and decriminalized, keep an eye on our legal guide, which is constantly being updated to reflect changes in regulations.
Read more
From New Atlas:
“There is plenty of disagreement in the psychedelic community over how to end the drug war and achieve broader legalization.”
“Most psychedelic advocates picture a future where the drug war is over and people are free to responsibly use a number of currently illicit substances for healing, personal growth, or simple recreation. “
“But exactly how we get to that utopian future is the source of great acrimony and division in a once-unified alternative community that is increasingly moving towards the mainstream.”
Read more
Amy Emerson is the Chief Executive Officer at the MAPS Public Benefit Corporation (MAPS PBC), a fully owned subsidiary of the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS).
Working for almost two decades to make MDMA a legal, FDA-approved medicine, Amy began as a pro bono consultant for MAPS in 2003, helping to create MAPS’ clinical department and managing the MDMA Clinical Development Program.
Her painstaking time and efforts have played a key role in seeing MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) through clinical trials, driving it ever-closer to being a legal, accessible therapeutic treatment in the US and abroad.
Read more